Related Experiment Videos
The surgical treatment of constrictive fibrous endocarditis
Insights
Loëffler syndrome, or constrictive fibrous endocarditis, is a rare cardiac condition with unknown causes. Surgical intervention involving fibrosis resection and valve replacement offers a potential treatment for this fatal disease.
Area of Science:
- Cardiology
- Pathology
- Cardiac Surgery
Background:
- Constrictive fibrous endocarditis, first described by Loëffler in 1936, is a rare cardiac pathology.
- The etiology of this condition remains unknown.
- It typically progresses to severe cardiac insufficiency and has a poor prognosis.
Observation:
- Clinical presentation involves rapid deterioration towards fatal cardiac failure.
- Diagnostic tools include cardiac catheterization to confirm adiastole and ventriculography to visualize ventricular amputation and auriculoventricular regurgitation.
Findings:
- The operative procedure involves resection of ventricular fibrotic tissue and auriculoventricular valve replacement with a prosthetic valve.
- The disease affects diverse populations, including Caucasians and Black individuals.
- The study discusses the indications for surgery and presents results from 5 patient cases.
Implications:
- Early and accurate diagnosis through modern paraclinical investigations is crucial.
- Surgical management offers a therapeutic option for constrictive fibrous endocarditis.
- Further research into the etiology and long-term outcomes of surgical intervention is warranted.
Abstract:
Constrictive fibrous endocarditis is a pathological entity described by Loëffler in 1936. Its etiology is unknown. The clinical course is characterized by an evolution towards cardiac insufficiency leading rapidly to a fatal outcome. Moderen paraclinical investigations are necessary to assess the diagnostic. Caridac catheterization brings the proof of adiastole and angiogardiography reveals the shape of amputation of the ventricle with auriculoventricular regurgitation. The operative procedure consists of resection of the ventricular fibrosis including the valves and auriculo-ventricular valve replacement by a prosthetic valve. The disease affects both Caucasians and Negros. Our experience includes 5 cases. The indications for operation and their results are discussed.